TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FDMT

4D Molecular Therapeutics Inc

Healthcare · Biotechnology · —

14.50$ -1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

4D Molecular Therapeutics Inc (FDMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 493 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FDMT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
362 340 630 620 604 560 516 474 424 567 513 493
328 297 536 553 511 435 333 303 312 413 405 383
276 249 276 189 188 149 134 77 49 60 72 70
320 288 526 542 502 425 321 293 305 403 391 361
– – – – – – – – – – – 4.6
32 32 29 32 51 50 46 53 55 61 61 85
18 19 16 19 29 29 27 35 37 44 43 48
3.1 3.1 3.2 3.2 5.1 5.6 5.7 5.7 5.7 5.6 5.5 5.4
4.7 3.5 4.2 3.4 2.9 4.4 4.2 8.7 6.9 11 15 13
– – – – – – – – – – – 20
330 308 601 588 553 511 470 421 369 506 452 408
-383 -415 -448 -483 -527 -576 -624 -679 -736 -716 -785 -858
42 39 49 55 56 54 56 56 56 58 68 70

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?